Teva Posts 2021 Earnings and Puts Opioid Litigation in Rearview Mirror | BioSpace
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Teva Announces Launch of $2 Billion (Equivalent) Offering of Sustainability-Linked Senior Notes - ESG News
Teva Announces Launch of Generic Epiduo® in the United States | World Pharma Today
Schultz kept Teva away from the abyss, but couldn't find a runway to growth | Ctech
Teva Pharmaceutical Initiated at Market Perform at BMO - TheStreet
Teva bought the pharm, and now it may have bought the farm | The Times of Israel
Drug Maker Teva to Pay Over $500 Million in New York Drug Case Settlement - The New York Times
Teva to acquire Allergan for $40B
Teva Pharmaceutical Industries (TEVA) Stock Price, News & Info | The Motley Fool
TEVA Soars after Catching Analyst Upgrade - TipRanks.com
Teva to Launch New Growth Strategy at Investor Day
Premarket Mover: Teva Pharmaceutical Industries Ltd (TEVA) Up 2.44%
Teva recalls US-made drugs following contamination fears - The Boston Globe
Teva enters opioid settlement agreement with US state Rhode Island
Teva quits brand lobby PhRMA, in line to lead generic lobby AAM - STAT
teva News and latest stories | The Jerusalem Post
Teva Pharmaceuticals: Israeli drugmaker to cut 14,000 jobs - BBC News
Teva shares approach 20-year low amid Moody's warning and other woes | Fierce Pharma
Teva Pharmaceuticals (@TevaUSA) / Twitter
Teva, workers sign accord on Jerusalem factory closure terms | The Times of Israel
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
TEVA.N - | Stock Price & Latest News | Reuters
Teva Pharmaceutical Stock: 3 Reasons To Buy Teva At $10 (NYSE:TEVA) | Seeking Alpha
Amid US drug shortages, Teva plots cuts to its generics portfolio
